Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Diabetologia 64(5):954962
Quick Answer: GLP-1 receptor agonists may reduce alcohol cravings in some individuals, but they are not FDA-approved for treating alcohol use disorder and evidence remains preliminary
This section outlines how to work with your provider to create a plan for coming off the medication and sustaining your results for the long term
In a 48-week clinical trial, higher doses consistently led to greater average weight loss: Weight loss by dose (48-week clinical trial) In this trial, at the highest dose (12 mg), people lost an average 24% of their starting weight on average
US$ 22.87
US$ 23.68
US$ 21.78
US$ 22.51
US$ 23.58
US$ 28.73
US$ 27.61
US$ 28.15
US$ 21.18
US$ 29.23
US$ 27.81
